A flow cytometry evaluation of anti-FVIII antibodies: Correlation with ELISA and Bethesda assay

Haemophilia

Volumn 17, Issue 2, 2011, Pages 267-274

  Irigoyen, M B ^a   Primiani, L ^b   Felippo, M ^a   Candela, M ^a   Bianco, R Perez ^a   De Bracco, M M DE E ^a   Galassi, N ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b Ciudad Autónoma de Buenos Aires   (Argentina)

Author keywords

Flow cytometry; FVIII antibodies; Haemophilia A; Microspheres

Indexed keywords

BLOOD CLOTTING FACTOR 8 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MICROSPHERE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANTIBODY DETECTION; ARTICLE; BETHESDA ASSAY; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DILUTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMOPHILIA A; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; SERUM;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; FLOW CYTOMETRY; HEMOPHILIA A; HUMANS; MICROSPHERES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 79951777994     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02406.x     Document Type: Article

References (22)

1. Lavigne-Lissalde G, Schved JF, Granier C, Villard S. Anti-factor VIII antibodies. A 2005 update. Thromb Haemost 2005; 94: 760-9.
2. Verbruggen B, Novakova I, Wessels H, Boezeman J, van der Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995; 73: 247-51.
3. Perez Bianco R, Castro Ozelo M, Ribeiro Villaça P et al. Diagnosis and treatment of congenital hemophilia with inhibitors. A Latin American perspectiva. Medicina (Buenos Aires) 2008; 68: 227-42.
4. Blanco A, Peirano A, Grosso S, Gennari L, Bianco RP, Lazzari M. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients. Haematologica 2000; 85: 1045-50.
5. Kazatchkine M, Sultan Y, Burton-Kee E, Mowbray J. Circulating immune complexes containing anti-FVIII antibodies in multi-transfused patients with haemophilia A. Clin Exp Immunol 1980; 39: 315-20.
6. Dazzi F, Tison T, Vianello F et al. High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII. Br J Haematol 1996; 93: 688-93.
7. Towfighi F, Gharagozlou S, Sharifian R et al. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity. Acta Haematol 2005; 114: 84-90.
8. Sahud M, Pratt K, Zhukov O, Qu K, Thompson A. ELISA system for detection of immune response to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 2007; 13: 317-22.
9. Ling M, Duncan E, Rodgers S, Street A, Lloyd J. Low detection rate of antibodies to non-functional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assay. J Thromb Haemost 2003; 1: 2548-53.
10. Vianello F, Radossi P, Tison T et al. Prevalence of anti-FVIII antibodies in severe haemophilia A patients with inversion of intron 22. Br J Haematol 1997; 97: 807-9.
11. Algiman M, Dietrich G, Nydegger U, Boieldieu D, Sultan Y, Kazatchkine M. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci USA 1992; 89: 3795-9.
12. Moreau A, Lacroix-Desmazes S, Stieltjes N et al. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG. Blood 2000; 95: 3435-41.
13. Gilles G, Saint-Remy J. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. J Clin Invest 1994; 94: 1496-505.
14. Scillian J, McHugh T, Busch M et al. Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay. Blood 1989; 73: 2041-8.
15. Martins T, Burlingame R, von Mühlen C, Jaskowski T, Litwin C, Hill H. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004; 11: 1054-9.
16. Wedemeyer N, Pascher E, Cassens U, Göhde W. Quantification of PCR products using microparticles and flow cytometry. Ann Biol Clin 2004; 62: 66-71.
17. Stewart M, Etches W, Shaw A, Gordon P. vWf inhibitor detection by competitive ELISA. J Immunol Methods 1997; 200: 113-9.
18. Giles A, Verbruggen B, Rivard G, Teitel J, Walker I. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the hemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. Thromb Haemost 1998; 79: 872-5.
19. Lavigne-Lissalde G, Tarrade C, Lapalud P et al. Simultaneous detection and epitope mapping of anti-factor VIII antibodies. Thromb Haemost 2008; 99: 1090-6.
20. Krudysz-Amblo J, Parhami-Seren B, Butenas S et al. Quantitation of anti-factor VIII antibodies in human plasma. Blood 2009; 113: 2587-94.
21. Reding M, Lei S, Lei H, Green D, Gill J, Conti-Fine B. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thromb Haemost 2002; 88: 568-75.
22. Ter Avest P, Fischer K, Mancuso M et al. Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice. J Thromb Haemost 2008; 6: 2048-54.